Evotec (EVO) News
NASDAQ: EVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.32-0.13 (-8.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
EVO news summary
We found 6 recent headlines mentioning Evotec (EVO): 3 in the past week and 4 in the past 30 days, most often from Nasdaq, PR Newswire. EVO is making an outsized move today, down 8.97% at $1.32, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Evotech & Bristol Myers Squibb Get IND Clearance For Second Molecular Glue Candidate", was published by Nasdaq on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Evotec headlines
- Evotech & Bristol Myers Squibb Get IND Clearance For Second Molecular Glue Candidate(RTTNews) - Thursday, Evotec SE (EVO) stated that the protein degradation partnership with Bristol Myers Squibb Co. (BMY) has been advanced further as yet another candidate received clearance of an…NasdaqBMY, EVO
- Evotec & Bristol Myers Squibb Get IND Clearance For Second Molecular Glue Candidate(RTTNews) - Thursday, Evotec SE (EVO) stated that the protein degradation partnership with Bristol Myers Squibb Co. (BMY) has been advanced further as yet another candidate received clearance of an…NasdaqBMY, EVO
- Evotec and Bristol Myers Squibb Advance Strategic Protein Degradation Partnership with Second IND AcceptanceFDA clearance expands partnered molecular glue pipeline Achievement underscores productivity of the collaboration in molecular glue discovery and potential to address patient populations with high…PR Newswire
- Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026HAMBURG, Germany, Oct. 29, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) will hold a webcast and conference call to announce its financial results for the first nine…PR Newswire
- Evotec Appoints Former Novo Nordisk Executive Joanna Holbrook As Chief Scientific Officer; Stock Up(RTTNews) - Evotec SE (EVO, EVTG.DE, EVTCY.PK), a life science company, announced the appointment of Dr. Joanna Holbrook as Chief Scientific Officer and member of the management board, effective…NasdaqEVO, ET
- Evotec Sees 9-Month Results Above Market; Reiterates FY26 Outlook(RTTNews) - Evotec SE (EVTG.DE, EVTCY.PK, EVO), a German healthcare company, announced preliminary results for the first nine months of 2026 that came in above market expectations, while reaffirming…Nasdaq